Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.5K Buy
162
+2
+1% +$91 ﹤0.01% 1043
2026
Q2
$4.56K Buy
160
+8
+5% +$174 ﹤0.01% 1371
2026
Q1
$2.64K Buy
152
+7
+5% +$132 ﹤0.01% 1430
2025
Q4
$2.73K Buy
145
+13
+10% +$218 ﹤0.01% 1333
2025
Q3
$1.92K Buy
132
+130
+6,500% +$1.85K ﹤0.01% 1476
2025
Q2
$40 Buy
+2
New +$36 ﹤0.01% 2420
2025
Q1
– Sell
-380
Closed -$8.14K – 2654
2024
Q4
$8.14K Buy
380
+79
+26% +$1.92K ﹤0.01% 451
2024
Q3
$9.4K Buy
+301
New +$7.49K ﹤0.01% 432

Other funds holding CDNA

True Wealth Design's CDNA Position: Q3 2026 in Review

True Wealth Design increased its CareDx (CDNA) stake by 1.3% in Q3 2026, buying an estimated $91 and bringing the position to 162 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1043.

True Wealth Design first reported a position in CDNA in Q3 2024 and has held it in 8 quarters since. 9 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • True Wealth Design held 162 shares of CareDx worth $10.5K as of Q3 2026.
  • True Wealth Design bought 2 CareDx shares in Q3 2026, an estimated $91.
  • CareDx made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1043 holding.
  • True Wealth Design first reported a position in CareDx in Q3 2024 and has held it in 8 quarters since.
  • 9 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.